________________________________________________________________________________
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Earliest Event Reported: May 10, 1999
MEDICIS PHARMACEUTICAL CORPORATION
________________________________________________________________________________
(Exact Name of Registrant as Specified in Charter)
Delaware 0-18443 52-1574808
(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)
4343 East Camelback Road
Phoenix, Arizona 85018
________________________________________________________________________________
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (602) 808-8800
-----------------------------
Not applicable
________________________________________________________________________________
(Former Name or Former Address, if Changes Since Last Report)
Item 5. Other Events
- ---------------------
On May 10, 1999, Medicis Pharmaceutical Corporation announced that the
Company's Board of Directors adopted a resolution authorizing the plan to
repurchase up to $75 million of the Company's common stock from time to time in
open market or privately negotiated transactions.
The timing and terms of the repurchases will be determined by
management based upon market conditions and corporate cash flow requirements.
This stock repurchase program is effective immediately.
The press release is attached hereto as Exhibit 99.
Item 7. Financial Statements and Exhibits
- ------------------------------------------
(c) Exhibits
EXHIBIT NUMBER DESCRIPTION
-------------- -----------
99 Press Release dated May 10, 1999.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
MEDICIS PHARMACEUTICAL CORPORATION
/S/ MARK A. PRYGOCKI, SR.
----------------------------------------------
Mark A. Prygocki, Sr.
Chief Financial Officer
Date: May 18, 1999.
EXHIBIT INDEX
Exhibit
Number Description
- ------ -----------
99 Press Release dated May 10, 1999.